Anabolic Steroids and Malnutrition in Chronic Renal Failure

Barton C.H. , Mirahmadi M.K. , Vaziri N.D. Effects of long-term testosterone administration on pituitarytesticular axis in end-stage renal failure. Nephron 1982; 31: 61–4.

Wilson J.D. Androgens. In: Goodman and Gilmans the pharmacological basis of therapeutics, 8th edition. New York: Pergamon Press Inc. 1990: 1413–30.

Forbes G.B. The effect of anabolic steroids on lean body mass: the dose response curve. Metabolism 1985; 34: 571–3.

Griggs R.C. , Kingston W. , Jozefowicz R.F. , Herr B.E. , Forbes A. , Haiiiday D. Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol 1989; 66: 498–503.

Jones R.W.A. , El Bishti M.M. , Bloom S.R. The effects of anabolic steroids on growth, body composition, and metabolism in boys with chronic renal failure on regular hemodialysis. J Pediatr 1980; 97–4: 559–66.

Brotherton J. Anabolic steroid therapy. In: Sex hormone pharmacology. London: Academic Press Inc., 1976: 353.

Wilson J.D. , Griffin J.E. The use and misuse of androgens. Metabolism 1980; 29: 1278–95.

DeGowin R.L. , Lavender A.R. , Forland M. , Charleston D. , Gottschalk A. Erythropoiesis and erythropoietin in patients with chronic renal failure treated with hemodialysis and testosterone. Ann Intern Med 1970; 72: 913–18.

Eschbach J.W. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int 1989; 35: 134–48.

Cattran D.C. , Fenton S.S.A. , Wilson D.R. , Oreopoulos D.G. , Shimizu A. , Richardson R.M. A controlled trial of nandrolone decanoate in the treatment of uremic anaemia. Kidney Int 1977; 12: 430–6.

Von Hartizsch B. , Kerr D.N.S. , Morley G. Androgens in the anemia of chronic renal failure. Nephron 1977; 18: 13–20.

Ballal S.H. , Domoto D.T. , Plack D.C. , Marciulonis P. , Martin K.J. Androgens potentiate the effects of erythropoietin in the treatment of anemia of endstage renal disease. Am J Kidney Dis 1991; 17: 29–33.

Berns J.S. , Rudnick M.R. , Cohen R.M. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis. Clin Nephrol 1992; 37(5): 264–7.

Ferraris J. , Saenger P. , Levine L. , New M. , Pang S. , Saxena B.B. , Lewy J.E. Delayed puberty in males with chronic renal failure. Kidney Int 1980; 18: 344–50.

Winer R.L. , Rajudin M.M. , Skowsky W.R. , Parker L.N. Preservation of normal adrenal androgen secretion in end stage renal disease. Metabolism 1982; 31: 269–73.

Ramirez G. , Butcher D. , Bruggemeyer C.D. Ganguly A. Testicular defect: the primary abnormality in gonadal dysfunction of uremia. South Med J 1987; 80: 698–701.

Handelsman D.I. Hypothalamic-pituitary gonadal dysfunction in renal failure. dialysis and renal transplantation. Endocr Rev 1985; 6(2): 151–82.

Campese V.M. , Liu C.L. Sexual dysfunction in uremia: endocrine and neurological alterations. Contrib Nephrol 1990; 77: 1–14.

Corvol B. , Bertagna X. , Bedrossian J. Increased steroid metabolic clearance rate in anephric patients. Acta Endocrinol 1974; 75: 756–61.

Stewart-Bentley M. , Gans D. , Horton R. Regulation of gonadal function in uremia. Metabolism 1974; 23: 106572.

Karacan I. , Salis P.J. Diagnosis and treatment of erectile impotence. Psychiatr Clin North Am 1980; 3: 97–111.

Procci W.R. , Goldstein D.A. , Adelstein J. , Massry S.G. Sexual dysfunction in the male patient with uremia: a reappraisal. Kidney Int 1981; 19: 317.

Holdsworth S.R. , de Krester D.M. , Atkins R.C. A comparison of hemodialysis and transplantation in re versing the uremic disturbance of male reproductive function. Clin Nephrol 1978; 10: 146.

Van Coevorden A. , Stolear J.C. , Dhaene M. , Van Herweghem J.L. , Mockel J. Effect of chronic oral testosterone undecanoate administration on the pituitary-testicular axes of hemodialyzed male patients. Clin Nephrol 1986; 26–1: 48–54.

Cunningham G.R. , Silverman V.E. , Thorn by J. , Kohler P.O. The potential for an androgen male contraceptive. J Clin Endocrinol Metab 1979; 49(4): 520–6.

Holma P. , Adlercreutz H. Effect of an anabolic steroid (metandienon) on plasma LH, FSH. and testosterone and on the response to intravenous administration of LRH. Acta Endocrinol 1976; 83: 856–64.

Knowlton K. , Kenyon A.T. , Sandiford I. , Lotwin G. , Fricker R. Comparative study of metabolic effects of estradiol benzoate and testosterone propionate in man. J Clin Endocrinol Metab 1942; 2: 671–84.

Masson G.M.C. , Corcoran A.C. , Page I.H. Dietary and hormonal influences in experimental uremia. J Lab Clin Med 1949; 34: 925.

Merrill J.P. The treatment of renal failure. New York: Grune and Stratton, 1955.

Derot M. , Bernier I.I. Testosterone in the treatment of nephritis with anuria: its effect upon azotemia. Bull Mem Soc Med Hop Paris 1950; 66(5,6): 205.

Boen S.T. Peritoneal dialysis. Netherlands, 1959.

McCracken B.H. , Parsons F.M. Use of nilevar (17-ethyl 19-nortestosterone) to suppress protein catabolism in acute renal failure. Lancet 1958; ii: 885.

Blagg C.R. , Parsons F.M. The use of norethandrolone in acute renal failure from obstetric causes. Lancet 1960; 2: 577.

Freedman P. , Spencer A.G. Testosterone propionate in the treatment of renal failure. Clin Sci 1957; 16: II.

Thaysen J.H. Anabolic steroids in the treatment of renal failure. In: Thaysen J.H. Protein metabolism. Berlin: Springer Verlag, 1962: 450–81.

Gjorup S. , Thaysen J.H. Anabolic steroids in treatment of uremia. Lancet 1958; 2: 866.

Malhotra K.K. , Suresh K.R. , Bansal R.C. Anabolicster oids in severe chronic renal failure. J Assoc Physicians India 1984; 32(10): 878–80.

Rubin J.E. , Feinroth M.V. , Feinroth M. , Berlyne G.M. Fall in serum creatinine in maintenance hemodialysis patients after cessation of anabolic steroids. Kidney Int 1981; 19: 158.

Abbott W.E. , Hirshfeld J.W. , Williams H.H. , Pilling M.A. , Meyer F.L. Metabolic alterations following thermal burns VI. The effect of altering the nitrogen and calorie intake or of administering testosterone propionate on the nitrogen balance. Surgery 1946; 20: 28494.

Ackermann P.G. , Kheim T. The effect of testosterone on plasma amino acid levels in elderly individuals. J Gerontol 1964; 19: 207–10.

Young G.A. , Yule A.G. , Hill G.L. Effects of an anabolic steroid on plasma amino acids, proteins and body composition in patients receiving intravenous hyperalimentation. JPEN J Parenter Enteral Nutr 1983; 7–3: 221–5.

Tweedle D. , Walton C. , Johnston I.D.A. The effect of an anabolic steroid on postoperative nitrogen balance. Br J Clin Pract 1973; 27: 130–2.